Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
# MC2030
Chicago, IL 60637Phone+1 773-702-1061
Education & Training
NIH Clinical CenterPost-Doctoral Fellowship, 2002 - 2007
Memorial Sloan Kettering Cancer CenterFellowship, 2000 - 2002
University of ChicagoChief Residency, Neurology, 1999 - 2000- University of ChicagoResidency, Neurology, 1997 - 2000
- University of Chicago (NorthShore)Internship, Transitional Year, 1996 - 1997
Loma Linda University School of MedicineClass of 1996- Loma Linda UniversityFellowship, 1993 - 1994
Certifications & Licensure
IL State Medical License 1996 - 2026- IL State Medical License 2018 - 2026
NJ State Medical License 2023 - 2025
PA State Medical License 2007 - 2010
NY State Medical License 2000 - 2008- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- Merit and Career Development Awards American Society of Clinical Oncology
Clinical Trials
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma Start of enrollment: 2011 Oct 01
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma Start of enrollment: 2015 May 01
- Biomarker Analysis of Central Nervous System Tumors Start of enrollment: 2016 Feb 25
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsCytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint BlockadeJohn Lynes, Sadhana Jackson, Victoria Sanchez, Gifty Dominah, Xiang Wang
Neurosurgery. 2019-04-01 - 502 citationsHypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.A Soeda, M Park, Dae Hee Lee, Arlan Mintz, Andreas Androutsellis-Theotokis
Oncogene. 2009-11-12 - 292 citationsDexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J. Giles, Marsha Kay N.D. Hutchinson, Heather Sonnemann, Jinkyu Jung, Peter E. Fecci
Journal for Immunotherapy of Cancer. 2018-06-11
Journal Articles
- Clinical Decision Making in the Era of Immunotherapy for High Grade-Glioma: Report of Four CasesMartha Quezado, Brett J Theeler, Deric M Park, Edjah Nduom, Nancy Garren, Surabhi Ranjan, Kareem A Zaghloul, BioMed Central
Professional Memberships
- Fellow
Other Languages
- Korean
Industry Relationships
- Scientific Advisor, Innate Repair2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
